idarubicin has been researched along with Thrombosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dailey, ME; Gorgan, MA; Mar, N; Vredenburgh, JJ | 1 |
| Borrelli, M; Ciccone, M; Cuneo, A; Rigolin, GM; Serino, ML; Viglione, GM | 1 |
| Albayram, S; Bariş, S; Celkan, T; Doğru, O; Kiliçaslan, I; Ozdemir, N; Ozdil, M; Sever, L; Topal, N | 1 |
| Farah, RA; Farhat, HZ; Jalkh, KS; Kadri, AM; Sayad, PE | 1 |
| Avvisati, G; Breccia, M; Carmosino, I; Cimino, G; De Propris, MS; Gentilini, F; Guarini, A; Latagliata, R; Lo-Coco, F; Mandelli, F; Petti, MC | 1 |
| Escudier, SM; Estey, EH; Kantarjian, HM | 1 |
2 trial(s) available for idarubicin and Thrombosis
| Article | Year |
|---|---|
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; CD2 Antigens; Female; fms-Like Tyrosine Kinase 3; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocyte Count; Lewis X Antigen; Male; Middle Aged; Mutation; Predictive Value of Tests; Risk Factors; Tandem Repeat Sequences; Thrombosis; Tretinoin | 2007 |
Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Topics: Adult; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cohort Studies; Cytarabine; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Germinoma; Hemorrhage; Humans; Idarubicin; Incidence; Infarction; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Melanoma; Middle Aged; Myocardial Infarction; Neoplasms, Multiple Primary; Remission Induction; Retrospective Studies; Spleen; Thrombosis; Treatment Outcome; Tretinoin | 1996 |
4 other study(ies) available for idarubicin and Thrombosis
| Article | Year |
|---|---|
Blue toes and a new pair of shoes--challenges in diagnosis and treatment of acute myelogenous leukemia.
Topics: Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Arterial Occlusive Diseases; Bone Marrow Examination; Combined Modality Therapy; Cyanosis; Cytarabine; Diagnosis, Differential; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Humans; Idarubicin; Ischemia; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Shoes; Thrombectomy; Thrombocytopenia; Thrombosis; Toes; Ultrasonography | 2013 |
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Sinus Thrombosis, Intracranial; Thrombosis; Tretinoin | 2008 |
Acute promyelocytic leukemia treated with idarubicin complicated by focal segmental glomerulosclerosis.
Topics: Antibiotics, Antineoplastic; Child; Glomerulosclerosis, Focal Segmental; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Nephrotic Syndrome; Thrombosis | 2010 |
Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cholecystectomy; Cytarabine; Etoposide; Fibrin Fibrinogen Degradation Products; Fibrinogen; Gallbladder; Heparin, Low-Molecular-Weight; Humans; Idarubicin; Infarction; Kidney; Lebanon; Leukemia, Myeloid, Acute; Male; Protein C; Protein C Deficiency; Remission Induction; Splenectomy; Splenic Infarction; Thrombosis; Tretinoin | 2011 |